Biblio

33557 resultats trouvés
C
Nadon V., Molto A., Etcheto A., Bessette L., Michou L., Claudepierre P., Wendling D., Tkaczyk C., Haraoui B., Dougados M..  2017.  CLINICAL CHARACTERISTICS OF SPONDYLARTHRITIS (SPA) WITH AND WITHOUT PERIPHERAL ENTHESITIS - DATA FROM THE DESIR COHORT. ANNALS OF THE RHEUMATIC DISEASES. 76:1303.
Heide S., T. de Villemeur B, Nava C., Rastetter A., Mignot C., Depienne C., Keren B., Chantot-Bastaraud S., Attie-Bitach T., Boutaud L. et al..  2018.  Clinical, chromosomal and molecular characterization of patients with agenesis of the corpus callosum. EUROPEAN JOURNAL OF HUMAN GENETICS. 26:365.
Shemer A., Sakka N., Baran R., Scher R., Amichai B., Norman L., Farhi R., Magun R., Brazilai A., Daniel R..  2015.  Clinical comparison and complete cure rates of terbinafine efficacy in affected onychomycotic toenails. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 29:521-526.
Lehalle D, Altunoglu U, Bruel A-L, Arnaud E, Blanchet P, Choi J-W, Desir J, Kilic E, Lederer D, Pinson L et al..  2017.  Clinical delineation of a subtype of frontonasal dysplasia with creased nasal ridge and upper limb anomalies: Report of six unrelated patients. AMERICAN JOURNAL OF MEDICAL GENETICS PART A. 173:3136-3142.
Lehalle D., Altunoglu U., Bruel A., Blanchet P., Choi J., Desir J., Duffourd Y., Kayserili H., Kilic E., Lederer D. et al..  2018.  Clinical delineation of a subtype of frontonasal dysplasia with creased nasal dorsum and limb anomalies: report of six novel cases and review of the literature. EUROPEAN JOURNAL OF HUMAN GENETICS. 26:472.
Lehalle D., Altunoglu U., Bruel A., Blanchet P., Choi J., Desir J., Duffourd Y., Kayserili H., Kilic E., Lederer D. et al..  2018.  Clinical delineation of a subtype of frontonasal dysplasia with creased nasal dorsum and limb anomalies: report of six novel cases and review of the literature. EUROPEAN JOURNAL OF HUMAN GENETICS. 26:472.
Carmignac V., Nambot S., Lehalle D., Callier P., Ghoumid J., Smol T., Thuillier C., Zordan C., Bienvenu T., Touraine R. et al..  2018.  Clinical delineation of the phenotype of five females carrying heterozygous mutation in KDM5C gene. EUROPEAN JOURNAL OF HUMAN GENETICS. 26:344-345.
Carmignac V., Nambot S., Lehalle D., Callier P., Ghoumid J., Smol T., Thuillier C., Zordan C., Bienvenu T., Touraine R. et al..  2018.  Clinical delineation of the phenotype of five females carrying heterozygous mutation in KDM5C gene. EUROPEAN JOURNAL OF HUMAN GENETICS. 26:344-345.
Abdulla S, Adam I, Adjei GO, Adjuik MA, Alemayehu B, Allan R, Arinaitwe E, Ashley EA, Ba MS, Barennes H et al..  2015.  Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data. BMC MEDICINE. 13:212.
Ornetti P., Fortunet C., Morisset C., Gremeaux V., Maillefert J.F, Casillas J.M, Laroche D..  2015.  Clinical effectiveness and safety of a distraction-rotation knee brace for medial knee osteoarthritis. ANNALS OF PHYSICAL AND REHABILITATION MEDICINE. 58:126-131.
Besch G, Perrotti A, Mauny F, Puyraveau M, Baltres M, Flicoteaux G, Mont LSalomon Du, Barrucand B, Samain E, Chocron S et al..  2017.  Clinical Effectiveness of Intravenous Exenatide Infusion in Perioperative Glycemic Control after Coronary Artery Bypass Graft Surgery A Phase II/III Randomized Trial. ANESTHESIOLOGY. 127:775-787.
Clement J-C, Besch G, Puyraveau M, Grelet T, Ferreira D, Vettoretti L, Pili-Floury S, Samain E, Berthier F.  2019.  Clinical effectiveness of single dose of intravenous dexamethasone on the duration of ropivacaine axillary brachial plexus block: the randomized placebo-controlled ADEXA trial. REGIONAL ANESTHESIA AND PAIN MEDICINE. 44:370-374.
Guenancia C, Stamboul K, Hachet O, Yameogo V, Garnier F, Gudjoncik A, Cottin Y, Lorgis L.  2016.  Clinical effectiveness of the systematic use of the GRACE scoring system (in addition to clinical assessment) for ischaemic outcomes and bleeding complications in the management of NSTEMI compared with clinical assessment alone: a prospective study. HEART AND VESSELS. 31:897-906.
Chenet J, Dupont E, Mont LSalomon du, Levy T, Salignon V, Puyraveau M, Pili-Floury S, Samain E, Besch G.  2020.  Clinical effectiveness of ultrasound-guided dual transversus abdominis plane block for postoperative analgesia in open abdominal aortic surgery patients The randomised, double-blind ETAP trial. EUROPEAN JOURNAL OF ANAESTHESIOLOGY. 37:821-823.
Giugliano RP, Pedersen TR, Park J-G, De Ferrari GM, Gaciong ZA, Ceska R, Toth K, Gouni-Berthold I, Lopez-Miranda J, Schiele F et al..  2017.  Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial. LANCET. 390:1962-1971.
Elhomsy S, Chrusciel J, Sanchez S, Elhomsy P, Guillaumat J.  2022.  Clinical Efficacy and Safety of Long-Term Compression in Patients with Mixed Arterial and Venous Etiology Ulcers in the Leg. INTERNATIONAL JOURNAL OF ANGIOLOGY. 31:34-39.
Regny C, Malak S, Manson G, Sarkozy C, Clavert A, Herbaux C, Chauchet A, Jourdan E, Sanhes L, Godmer P et al..  2016.  Clinical Efficacy of the Rivbd Combination for Refractory/Relapsed (R/R) Mantle Cell Lymphoma (MCL) Patients: A Retrospective Study of the French Lysa Group. BLOOD. 128
Regny C, Malak S, Manson G, Sarkozy C, Clavert A, Herbaux C, Chauchet A, Jourdan E, Sanhes L, Godmer P et al..  2016.  Clinical Efficacy of the Rivbd Combination for Refractory/Relapsed (R/R) Mantle Cell Lymphoma (MCL) Patients: A Retrospective Study of the French Lysa Group. BLOOD. 128
Regny C, Malak S, Manson G, Sarkozy C, Clavert A, Herbaux C, Chauchet A, Jourdan E, Sanhes L, Godmer P et al..  2016.  Clinical Efficacy of the Rivbd Combination for Refractory/Relapsed (R/R) Mantle Cell Lymphoma (MCL) Patients: A Retrospective Study of the French Lysa Group. BLOOD. 128
Toussirot E., Martin A., Soubrier M., Redeker S., Regent A., CRI L.  2015.  CLINICAL EFFICACY OF TOCILIZUMAB IN POLYMYALGIA RHEUMATICA: AN OPEN-LABEL STUDY. ANNALS OF THE RHEUMATIC DISEASES. 74:516.
Toussirot E, Martin A, Soubrier M, Redeker S, Regent A, Cri L.  2015.  Clinical Efficacy of Tocilizumab in Polymyalgia Rheumatica: An OPEN-Label Study. ARTHRITIS & RHEUMATOLOGY. 67
Toussirot E, Martin A, Soubrier M, Redeker S, Regent A, Cri L.  2015.  Clinical Efficacy of Tocilizumab in Polymyalgia Rheumatica: An OPEN-Label Study. ARTHRITIS & RHEUMATOLOGY. 67
Toussirot E., Martin A., Soubrier M., Redeker S., Regent A..  2016.  Clinical efficacy of tocilizumab in polymylagia rheumatica: an open label study. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 30:34.
Toussirot E., Martin A., Soubrier M., Redeker S., Regent A..  2016.  Clinical efficacy of tocilizumab in polymylagia rheumatica: an open label study. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 30:34.
Mahamat A, Bertrand X, Moreau B, Hommel D, Couppie P, Simonnet C, Kallel H, Demar M, Djossou F, Nacher M.  2016.  Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 48:51-55.

Pages